Monday, August 26, 2019

NSE to exclude F&O contracts on Strides Pharma from November 1

NSE mentioned in the note that the company does not meet the enhanced eligibility criteria to remain in the derivatives segment.

from India Infoline News Service https://ift.tt/329ChSj
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)